http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103784466-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed44f9f631847c7b10928366d580e690 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6647f7fcf30bf9b367d9e78f53b805a0 |
| publicationDate | 2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103784466-A |
| titleOfInvention | Pharmaceutical composition for treating venous thrombosis |
| abstract | The invention discloses a pharmaceutical composition for treating venous thrombosis. The composition comprises 4-methyl-2-oxo-2H-1-benzopyran-7-yl 1,5-dithio-beta-D-xylopyranoside and [1,2,4]triazolo[1,5-a]pyridine-8-yl 5-thio-beta-D-xylopyranoside, and the molar ratio of 4-methyl-2-oxo-2H-1-benzopyran-7-yl 1,5-dithio-beta-D-xylopyranoside to [1,2,4]triazolo[1,5-a]pyridine-8-yl 5-thio-beta-D-xylopyranoside is 2:1 to 1:2. The two specific xylopyranosides are screened from the prior art for compounding, and the obtained composition has better curative effect on venous thrombosis. |
| priorityDate | 2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.